Abstract: Nano technology is a multidisciplinary field, which recently has emerged as one of the most propitious field in cancer treatment. Nano technology is definitely a medical boom for diagnosis, treatment and prevention of cancer disease. It supports and expands the scientific advances in genomic and proteomics and builds on our understanding of the molecular underpinnings of cancer and its treatment.

Abstract: Pill-swallowing difficulty primarily affects the geriatric and pediatric populations whereas unpalatable taste of drugs leads to patient non-compliance. To eliminate these problems, a new dosage form known as fast-dissolving tablet (FDT), has been developed like fast-melt or fast disintegrating or orally disintegrating tablets (ODTs). In April 2007, the FDA issued a draft guidance, Guidance for Industry: Orally Disintegrating Tablets. Fast dissolving tablets can be prepared by various conventional methods like direct compression, wet granulation, moulding, spray drying, freeze drying, and sublimation. In 1986, the first lyophilized fast-dissolving technology Zydis® was introduced (By Cardinal formerly R. P. Scherer) after that there was a continuous growth in names by different companies, now a number of fast-dissolving formulations are in market and the technology is still improving. Present review focuses on the need of FDTs, their advantages and comparative evaluation of latest technologies.

Abstract: There are a number of formulations containing radioisotopes, which are used internally for therapeutic and diagnostic purposes. These preparations are referred to collectively as radiopharmaceuticals1. Radiopharmaceuticals have revolutionized the medical field by their ability to provide static as well as dynamic images of internal organs in a noninvasive manner as well as by offering efficacious therapy of certain diseases. In practice, the majority of radiopharmaceuticals are used for diagnosis, but increasingly, highly specific radiotherapeutic agents are being developed which have the potential for delivery of effective treatment, particularly in cancer therapy. Using products of proven quality is vital to achieve successful outcomes in both the diagnostic and therapeutic use of radiopharmaceuticals.

Abstract: The stability indicating method can be defined as Validated Quantitative analytical method that can detect the change with time in the chemical, physical or microbiological properties of the drug substance and drug product, and that are specific so that the content of active ingredient, degradation can be accurately measured without interference.